Brainstorm Cell Therapeutics reported 0.03 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Biogen 29.15 5.92 Sep/2026
Brainstorm Cell Therapeutics 0.03 5.89 Sep/2025
Cipla 38.39 2.57 Sep/2026
Clal Biotechnology 11.67 2.62 Dec/2022
Compugen 5.58 0.12 Jun/2026
CSL 16.16 9.59 Dec/2025
Gilead Sciences 17.68 4.18 Sep/2026
Grifols 11.2 1.08 Dec/2025
Halozyme Therapeutics 16.12 3.61 Sep/2026